Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00350480 · ClinicalTrials.gov registry record · NA
Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT00350480 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 240 participants.
The verdict
NCT00350480, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
To determine the relative efficacy of multidose medroxyprogesterone acetate (MPA, Provera) and a multidose, monophasic combination oral contraceptive in the treatment of hemodynamically stable women with non-gestational, acute uterine bleeding.
Interventions
- DRUG Provera
- DRUG Combination Birth Control pills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2003-04 |
| Est. Completion | 2005-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00350480
The ClinicalTrials.gov registry entry for NCT00350480 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Provera is the first listed.
NCT00350480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00350480 about?
NCT00350480 is a clinical study titled "Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial". To determine the relative efficacy of multidose medroxyprogesterone acetate (MPA, Provera) and a multidose, monophasic combination oral contraceptive in the treatment of hemodynamically stable women with non-gestational, acute uterine bleeding.
What is the current status of trial NCT00350480?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2003-04. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00350480?
The interventions under investigation include: Provera (DRUG), Combination Birth Control pills (DRUG).
Who is sponsoring clinical trial NCT00350480?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.